Desmond Roche

648 total citations
8 papers, 537 citations indexed

About

Desmond Roche is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Desmond Roche has authored 8 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Oncology. Recurrent topics in Desmond Roche's work include Cell death mechanisms and regulation (6 papers), Phagocytosis and Immune Regulation (3 papers) and Hepatitis B Virus Studies (2 papers). Desmond Roche is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Phagocytosis and Immune Regulation (3 papers) and Hepatitis B Virus Studies (2 papers). Desmond Roche collaborates with scholars based in Ireland. Desmond Roche's co-authors include Fergus Shanahan, Michael Bennett, Gerald C. O’Sullivan, Joe O’Connell, John Collins, Kevin Collins, Claire Brady, J O’Connell, J. Kelly and G. C. O’Sullivan and has published in prestigious journals such as The Journal of Immunology, Gut and International Journal of Cancer.

In The Last Decade

Desmond Roche

8 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Desmond Roche Ireland 6 340 280 222 78 53 8 537
K Imai Japan 12 265 0.8× 129 0.5× 170 0.8× 70 0.9× 23 0.4× 14 423
T Osaki Japan 6 240 0.7× 233 0.8× 133 0.6× 58 0.7× 28 0.5× 9 427
Hideo Takasu Japan 10 320 0.9× 360 1.3× 226 1.0× 70 0.9× 24 0.5× 15 571
L Lauerová Czechia 11 159 0.5× 173 0.6× 231 1.0× 35 0.4× 29 0.5× 31 416
Valeria Cambiaghi Italy 9 335 1.0× 126 0.5× 168 0.8× 85 1.1× 76 1.4× 10 520
Satoko Inoda Japan 11 296 0.9× 187 0.7× 330 1.5× 118 1.5× 31 0.6× 12 552
Ilaria Cattarossi Italy 11 309 0.9× 336 1.2× 154 0.7× 44 0.6× 23 0.4× 14 569
Jenny L. Weon United States 5 391 1.1× 216 0.8× 137 0.6× 80 1.0× 80 1.5× 6 523
Hannah J. Whiteman United Kingdom 7 250 0.7× 89 0.3× 152 0.7× 109 1.4× 26 0.5× 7 409
Kazuyo Yasuda Japan 15 351 1.0× 124 0.4× 279 1.3× 128 1.6× 23 0.4× 24 585

Countries citing papers authored by Desmond Roche

Since Specialization
Citations

This map shows the geographic impact of Desmond Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desmond Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desmond Roche more than expected).

Fields of papers citing papers by Desmond Roche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desmond Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desmond Roche. The network helps show where Desmond Roche may publish in the future.

Co-authorship network of co-authors of Desmond Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Desmond Roche. A scholar is included among the top collaborators of Desmond Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desmond Roche. Desmond Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Houston, Aileen, Frank Waldron-Lynch, Michael Bennett, et al.. (2003). Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo. International Journal of Cancer. 107(2). 209–214. 20 indexed citations
2.
Roche, Desmond, et al.. (2000). Information processes in support of innovation. International Journal of Technology Management. 20(5/6/7/8). 556–556. 1 indexed citations
3.
Bennett, Michael, J O’Connell, Gerald C. O’Sullivan, et al.. (1999). Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut. 44(2). 156–162. 105 indexed citations
4.
Bennett, Michael, J O’Connell, G. C. O’Sullivan, et al.. (1999). Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover. Diseases of the Esophagus. 12(2). 90–98. 19 indexed citations
5.
O’Connell, Joe, Michael Bennett, Gerald C. O’Sullivan, et al.. (1998). Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. The Journal of Pathology. 186(3). 240–246. 107 indexed citations
6.
Bennett, Michael, Joe O’Connell, Gerald C. O’Sullivan, et al.. (1998). The Fas Counterattack In Vivo: Apoptotic Depletion of Tumor-Infiltrating Lymphocytes Associated with Fas Ligand Expression by Human Esophageal Carcinoma. The Journal of Immunology. 160(11). 5669–5675. 270 indexed citations
7.
O’Connell, Joe, Michael Bennett, Gerald C. O’Sullivan, et al.. (1998). Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. The Journal of Pathology. 186(3). 240–246. 14 indexed citations
8.
Roche, Desmond. (1969). Corticosteroids in laryngeal diphtheria.. BMJ. 1(5636). 119.1–119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026